Envoy Medical, Inc. (COCH) vs Rani Therapeutics Holdings, Inc. (RANI)
A side-by-side comparison of Envoy Medical, Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COCH
Envoy Medical, Inc.
$0.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RANI
Rani Therapeutics Holdings, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — COCH vs RANI
growth of $100 · dividends reinvested · last 5yCOCH -93.3% (-41.7%/yr)RANI -93.0% (-41.2%/yr)RANI compounded faster over this window
COCH RANI
COCH vs RANI: by the numbers
- •RANI is the larger company ($54M vs $50M market cap).
- •Both run net losses; RANI's is the smaller (-618.02% vs -11304.83% net margin).
Metrics side by side
Valuation
| Metric | COCH | RANI |
|---|---|---|
| P/S ratio | 242.85 | 11.10 |
| P/B ratio | 15.22 | 1.38 |
Profitability
| Metric | COCH | RANI |
|---|---|---|
| Gross margin | -262.66% | 44.89% |
| Operating margin | -9240.66% | -2345.99% |
| Net margin | -11304.83% | -618.02% |
| ROE | -708.48% | -76.82% |
| ROIC | -208.76% | -63.96% |
Growth (annualized)
| Metric | COCH | RANI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.95% |
| Total return CAGR (5Y) | -41.73% | -46.70% |
Frequently asked
- How have COCH and RANI total returns compared?
- Over the past 5 years, COCH delivered -41.73% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.